Weight-Loss Drug Wegovy Slashes Risk of Death in Some People with Heart Disease
The active ingredient in Wegovy and Ozempic reduced the risk of heart attacks and strokes in a large trial of people with cardiovascular disease who were considered overweight or had obesity, but the cost and side effects remain barriers
The active ingredient in Wegovy and Ozempic reduced the risk of heart attacks and strokes in a large trial of people with cardiovascular disease who were considered overweight or had obesity, but the cost and side effects remain barriers
What's Your Reaction?
SIN
ScienceX Information Network (SIN) | ScienceX Innovations
